Aberrant cytoplasmic expression of UHRF1 restrains the MHC-I-mediated anti-tumor immune response is a research paper published in Nature Communications (2024). On theSindex it has a DataRank of 0.606. It has been cited 15 times, with 14 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.416
From this paper's citation signal
Citation Network Contribution
0.190
From 14 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 14 citers.
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Grant: R01-CA233205
NCI NIH HHS
Grant: R01 CA233205
National Institutes of Health
Grant: 5R01CA233205-03
Targeting UHRF1 in combinational immunotherapy
FWCI
2.55
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals